FAA would publish and update approved medicine guidance for aviation workers

The FAA would publish and maintain a public list of medicines it has determined may be safely used and approved for aviation medical certification or clearance. The list concerns applicants for medical certification or clearance, including airmen and air traffic control specialists. The list covers medicines for treating conditions that may affect aviation duties or certificate privileges. The list must include allowed prescription and over-the-counter medicines, related risks, whether FAA review may be needed, and medicines on the Do Not Issue or Do Not Fly lists. The FAA would publish the list within one year after the Act is enacted, then update it within one year after publication and when relevant FAA medical guidance or policy changes.

The FAA would consult aviation and medical groups and make the list accessible online and through MedXPress. MedXPress access would cover airmen, air traffic control specialists, and people training for those roles when they first seek medical certification or clearance. The FAA must consult the listed labor, training, medical, and aviation groups, plus any other stakeholders it considers relevant. If practicable, the list would state how long a person may need limited or no duties while adjusting to an allowed medicine. It would also give medical providers a way to contact the FAA with questions. The list must be made available through MedXPress at the first request for medical certification or clearance.

Publishing the medicine list would not make the FAA liable for certain harms or certification decisions involving someone who relies on it. This applies when an airman, air traffic control specialist, or applicant relies on a medicine list published by the FAA. The limit covers adverse medical reactions, harm or injury to people or property, and a decision that the person is not eligible for certification or clearance.